← Evidence map

TrialClinical and translational science2026

Safety and Pharmacokinetics of Olamkicept Doses up to 2400 mg in Healthy Japanese Men: Phase I, Randomized, Placebo-Controlled, and Double-Blind Trial.

Ryuzo Hanada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 42503008